Glycerinum (Glycerol) Veterinary Grade API is a clear, syrupy, hygroscopic triol supplied as an anhydrous grade of 99.7% w/w minimum glycerol and, where specified, as an 85% w/w aqueous solution. Representative article designations are GLY-VET-API-99.7/0.5 and GLY-VET-API-85/0.1. The material is manufactured under a quality system aligned with EudraLex Volume 4 Part II and ICH Q7 for active pharmaceutical ingredients. Release testing includes the current USP–NF Glycerin monograph and Ph. Eur. monograph 0496 for Glycerol; the API is intended for veterinary tablets, injections, capsules, powders, granules, premixes, and solutions. The anhydrous grade shows lot-release specific gravity of 1.260–1.263 g/cm³ at 20°C, refractive index 1.470–1.475 at 20°C, and dynamic viscosity of approximately 1410 mPa·s at 20°C and 934 mPa·s at 25°C. The limiting impurities diethylene glycol and ethylene glycol are controlled to ≤0.10% each by gas chromatographic limit test, consistent with current USP–NF and Ph. Eur. requirements for pharmaceutical-grade glycerin. Residual solvents are controlled to USP <467> for the synthetic or vegetable-derived process stream, and the parenteral grade carries bacterial endotoxin release data under USP <85> / Ph. Eur. 2.6.14.

Specification Profile and Pharmacopoeial Test Matrix

The water limit is tighter than the USP–NF Glycerin monograph upper limit of ≤5.0% for general glycerin; the ≤0.5% threshold is imposed for the anhydrous veterinary API to support moisture-sensitive solid dosage forms and low-endotoxin parenteral manufacture.

Storage and transfer conditions for the anhydrous grade are governed by its equilibrium moisture sorption. In open vessels at 20°C and 60% RH, surface water uptake can reach 0.5% w/w within 4 h; drums should therefore be blanketed with nitrogen and opened only in dry transfer rooms where dew point is below -20°C for parenteral-grade material. Transfer from 1250 kg intermediate bulk containers through 25 mm stainless-steel lines at 35–45°C reduces viscosity sufficiently for volumetric metering; pumps should be positive-displacement gear or lobe type with mechanical seals rated for 180–250 L/h to avoid cavitation. Contact with carbon steel, copper, or copper alloys should be avoided for long-term storage because trace metal ions accelerate oxidation and color formation; 316L stainless steel or high-density polyethylene is acceptable. For material intended for parenteral batches, bioburden after transfer should be verified to remain below 10 CFU/100 mL before terminal filtration; open transfer under ISO Class 8 conditions is the minimum required. Batch-to-batch variance in water content and diethylene glycol concentration is monitored by statistical process control; for anhydrous grade, the moving range between consecutive water assays is typically 0.05% w/w, but excursions occur when drum desiccant cartridges are not replaced during high-humidity campaign periods. In parenteral-grade campaigns, final endotoxin rejection is most sensitive to the water used for transfer-line flushing; endotoxin levels can rise by 0.10–0.20 EU/mL if purified water remains in dead legs for more than 4 h at 20–25°C.

Tablet granulation operations with glycerol are performed by preparing a 30–40% w/w binder solution in purified water at 40–50°C. In a fluid-bed granulator with a 600 mm Wurster insert, spray rates of 0.20–0.35 L/min per 100 kg batch yielded granulations with median particle size 180–240 µm and Carr compressibility index 12–18%, evaluated according to USP <1174>. When glycerol is limited to 1.5–3.0% w/w of the dry blend, tablet tensile strength measured across a 16-station rotary tablet press at 12–20 kN main compression force remained 1.8–2.4 MPa; friability was below 0.2% after 100 rotations at 25 rpm under USP <1216>. At glycerol loadings above 4.0% w/w, sticking and picking on tooling were observed when ambient humidity exceeded 60% RH; pre-drying granulations to loss on drying 1.2–1.8% w/w and applying magnesium stearate at 0.5% w/w reduced tooling adhesion. Tablet formulations containing glycerol as binder show delayed dissolution when over-granulated; end-point determination by impeller torque or product temperature is preferred over fixed-time spray cycles.

What Limits Direct Substitution of Glycerol for Propylene Glycol in Injectable Veterinary Formulations?

Glycerol is not freely interchangeable with propylene glycol in parenteral vehicles. A 1.0% w/v aqueous glycerol solution contributes approximately 109 mOsm/kg to formulation osmolality, whereas propylene glycol contributes approximately 131 mOsm/kg at equivalent concentration. The higher dynamic viscosity of undiluted glycerol (1410 mPa·s at 20°C versus 48.6 mPa·s at 25°C for propylene glycol) necessitates heated transfer and dilution before sterile filtration; final aqueous vehicles containing 10–20% w/w glycerol exhibit viscosity below 2.0 mPa·s at 20°C and filter through 0.2 µm polyethersulfone cartridges without measurable flux decay. Terminal sterilization at 121°C for 15 min is applicable to glycerol-containing vehicles at 10–20% w/w; post-autoclave assay loss is typically less than 0.5% when headspace oxygen is displaced with nitrogen. Glycerol is endogenous and gluconeogenic, which reduces solvent-related neurotoxicity risk in cats compared with propylene glycol; however, high parenteral doses of glycerol can produce intravascular hemolysis, hyperglycemia, and osmotic diuresis. Published data for high-concentration glycerol injections in target veterinary species are limited; dose selection therefore requires species-specific osmolality, hematology, and glucose monitoring rather than direct substitution from propylene glycol formulas.

When Powder and Premix Carriers Demand Controlled Spray Loading of Glycerol

Powder and premix applications use glycerol as a binding humectant and dust-suppressing agent sprayed onto corn cob, lactose monohydrate, calcium carbonate, or silica carriers. A 50% w/w aqueous glycerol spray applied through a binary nozzle in a 500 kg ribbon blender at 20 rpm for 6–8 min produced blend uniformity with relative standard deviation below 5.0% when the final glycerol content was 0.5–1.5% w/w. At spray rates above 0.50 L/min, localized overwetting and agglomerates larger than 2.0 mm were observed in lactose-based premixes; these agglomerates persisted after 15 min additional mixing and required passage through a 1.0 mm conical screen. The grade used in premix formulations should be specified as low-water anhydrous material unless the premix manufacturing step includes final moisture adjustment; residual water from 85% glycerol solution can increase water activity above 0.60 in hygroscopic carriers and reduce microbial stability. When glycerol is used with silica carriers, the spray dispersion should be checked by 1 min tap density measurement after each 100 kg addition; increases above 10% relative to the ungranulated carrier indicate agglomeration.

Capsule Shell Plasticization and Moisture Sorption Boundaries

Capsule shell formulations use glycerol as a plasticizer at 15–25% w/w of dry gelatin; the triol lowers glass transition and increases elongation, but equilibrium moisture content of the shell rises as glycerol content increases. In softgel ribbon casting, glycerin levels above 25% w/w increase tack and blocking on rotary dies at relative humidity above 50%; shell moisture is therefore maintained at 6–8% and drying tunnel temperature at 20–25°C. Hard capsules incorporating glycerol in the shell polymer require control of aldehyde impurities in gelatin; residual aldehydes crosslink with glycerol and gelatin during storage at 40°C/75% RH, producing delayed dissolution. Dissolution testing should follow USP <711> apparatus criteria appropriate to the target veterinary species; published data for veterinary-specific dissolution acceptance criteria for glycerol-plasticized shells is limited.

Differences between this veterinary-grade API and technical-grade glycerol are defined by impurity policy rather than by triol content alone. Technical-grade glycerol may contain diethylene glycol above 1% w/w, chlorinated organics, and formaldehyde-reactive species; these are not addressed by the food additive monograph and are not suitable for parenteral or solid-dosage veterinary use. Food-grade glycerin conforming to FCC requirements may meet assay and heavy metal limits but is not controlled for bacterial endotoxins under USP <85> / Ph. Eur. 2.6.14, nor is it routinely tested for ethylene glycol and diethylene glycol at the pharmacopoeial threshold of ≤0.10% each. In comparison with sorbitol solution 70% w/w and polyethylene glycol 400, glycerol has higher hygroscopicity and a greater osmolar contribution per unit weight, which favors its use as a tablet humectant and soft-capsule plasticizer but narrows its parenteral concentration window.

Solution formulations for oral drench, drinking water, or parenteral administration require viscosity, pH, and osmolality control. Glycerol is freely miscible with water, ethanol, and propylene glycol; mixing anhydrous glycerol with water is exothermic, and controlled addition at 20–25°C avoids thermal degradation of heat-sensitive actives. Batch records from 1000 L stainless-steel mixing vessels show that addition of glycerol to cold water below 15°C increases local viscosity and extends mixing time to 45–60 min; pre-warming the water phase to 30–40°C before glycerol addition shortens homogenization to 15–20 min at 60–80 rpm. The pH of a 10% w/w aqueous solution is typically 5.5–7.5; buffering may be required for actives with narrow stability ranges. In oral drench products, glycerol at 10–30% w/w provides viscosity 2–6 mPa·s, sufficient to suspend micronized insoluble anthelmintics and improve palatability in cattle and swine. For injectable solutions, terminal sterilization is addressed above for parenteral vehicles; for oral solutions, microbial challenge testing should follow USP <51> or Ph. Eur. 5.1.3 when the product contains water at activity above 0.60.